Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$133,355
New position
Shares Held
5,538
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,506
of 2,820 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Markowski Investments holds $6,496,075 across 13 Drug Manufacturers - General names. PFE ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
10,631 | $2,675,184 | |
| 2 | LLY |
ELI LILLY & Co
|
1,821 | $2,184,162 | |
| 3 | AMGN |
Amgen Inc
|
1,471 | $532,678 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,585 | $332,172 | |
| 5 | JNJ |
Johnson & Johnson
|
1,237 | $314,160 | |
| 6 | PFE |
Pfizer Inc
This page
|
5,538 | $133,355 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
792 | $100,061 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,569 | $90,405 |
All Filings in PFE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,355 | 5,538 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||